Kitex Garments will form two new subsidiaries and invest Rs 200 crore in each of them.
Zydus Cadila gets final approval from U.S. FDA for Methylprednisolone.
Syngene International Q4 (YoY): Revenue up 40.5 % at Rs 409 crore. Net profit up 8 % at Rs 84 crore. Margin at 31.3 % versus 34.4 %.
Indiabulls Real Estate Q4 (YoY): Revenue at Rs 2,028 crore versus Rs 437 crore. Net profit at Rs 1,648 crore versus Rs 80 crore. Margin at 96.7 % versus 32.5 %.
Stocks To Watch:
Positive: #KITEX #CADILAHC #SYNGENE #IBREALEST
